Evaluation of human cerebrospinal fluid malate dehydrogenase 1 as a marker in genetic prion disease patients

HIGHLIGHTS

• who: Inga Zerr and collaborators from the Department of Neurology, National Reference Center for CJD Surveillance University Medical Center German Center for Neurodegenerative Diseases (DZNE)-Göttingen campus, Göttingen, Germany have published the Article: Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients, in the Journal: (JOURNAL)
• what: The authors determined the levels of CSF-MDH1 in a cohort of genetic prion disease patients.
• how: For comparison between more thanvs.two groups the authors used NC 71 35/36 61± 9 1172 ± 413 1075-1270 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.